Clinical Trials Logo

Post Liver Transplant clinical trials

View clinical trials related to Post Liver Transplant.

Filter by:
  • None
  • Page 1

NCT ID: NCT03386305 Recruiting - Clinical trials for Post Liver Transplant

Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant

Start date: December 13, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

This study will evaluate the medication adherence, clinical efficacy, and safety of EnvarsusXR in stable post liver transplant patient using a Phase III randomized controlled study. The primary outcome is change in medication adherence from baseline to the end of the study, assessed using a validated instrument (BAASIS- Basel Assessment of Adherence with Immunosuppressive medication Scales) and standard deviation of Tacrolimus levels.

NCT ID: NCT01687270 Completed - Clinical trials for Post Liver Transplant

Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant

Start date: November 2012
Phase: Phase 2
Study type: Interventional

This is an open-label, single-arm study of sofosbuvir (GS-7977) and ribavirin (RBV) in adults who have had a liver transplant which has become re-infected with hepatitis C. The treatment period is 24 weeks with up to 48 weeks of follow up. The total time in this study will last up to 72 weeks not including the screening visit.